Indeed, there is some evidence to suggest that Wee1 inhibition, albeit in combination with both radiation and cisplatin, produces dose-limiting toxicities in patients with HNSCC, which could in part be explained by our lack of knowledge of the normal tissue responses to this combinatorial treatment. Here, WEE1 is linked to head and neck squamous cell carcinoma.